J. Chehimi

发表

Retention of viability, cytotoxicity, and response to IL‐2, IL‐15, or IFN‐α by human NK cells after CD107a degranulation

L. Montaner, V. Maino, C. Tomescu, 2009, Journal of leukocyte biology.

Constitutive and induced expression of DC‐SIGN on dendritic cell and macrophage subpopulations in situ and in vitro

D. Weissman, R. Doms, J. Trowsdale, 2002, Journal of leukocyte biology.

Decreased natural killer (NK) cell function in chronic NK cell lymphocytosis associated with decreased surface expression of CD11b.

J. Orange, K. Sullivan, J. Chehimi, 2001, Clinical Immunology.

Sustained Impairment of IFN-γ Secretion in Suppressed HIV-Infected Patients Despite Mature NK Cell Recovery: Evidence for a Defective Reconstitution of Innate Immunity1

L. Montaner, E. Papasavvas, J. Kostman, 2002, The Journal of Immunology.

Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation.

G. Trinchieri, M. Kubin, M. Aste‐Amezaga, 1992, Progress in growth factor research.

In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates

B. Perussia, D. Campbell, H. Kawashima, 1991, Journal of virology.

Persistent Decreases in Blood Plasmacytoid Dendritic Cell Number and Function Despite Effective Highly Active Antiretroviral Therapy and Increased Blood Myeloid Dendritic Cells in HIV-Infected Individuals1

G. Trinchieri, L. Montaner, E. Papasavvas, 2002, The Journal of Immunology.

Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients

I. Frank, B. Perussia, M. Kobayashi, 1992, The Journal of experimental medicine.

Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors.

G. Trinchieri, T. Tursz, F. Mami-Chouaib, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Dendritic cells and IFN-alpha-producing cells are two functionally distinct non-B, non-monocytic HLA-DR+ cell subsets in human peripheral blood.

G. Trinchieri, B. Perussia, D. Miller, 1989, Immunology.

dendritic cell numbers and the production of cytokines populations: effects of CD40 ligand and treatment with GM-CSF on Sézary syndrome patients demonstrate a defect in dendritic cell

L. French, L. Montaner, A. Rook, 2013 .

Baseline Viral Load and Immune Activation Determine the Extent of Reconstitution of Innate Immune Effectors in HIV-1-Infected Subjects Undergoing Antiretroviral Treatment12

L. Montaner, J. Kostman, K. Mounzer, 2007, The Journal of Immunology.

Subjects Undergoing Antiretroviral Innate Immune Effectors in HIV-1-Infected Determine the Extent of Reconstitution of Baseline Viral Load and Immune Activation

L. Montaner, J. Kostman, K. Mounzer, 2007 .

Interleukin-12: A bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency

G. Trinchieri, J. Chehimi, 1994, Journal of Clinical Immunology.

Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients

P. Janmey, L. Montaner, E. Papasavvas, 2009, AIDS (London).

Functional interaction between TGF-beta and IL-12 in human primary allogeneic cytotoxicity and proliferative response.

F. Mami-Chouaib, S. Chouaib, J. Chehimi, 1997, Journal of immunology.

Sézary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines.

L. French, L. Montaner, A. Rook, 2002, Blood.

Differential regulation of interleukin‐12‐and interleukin‐15‐induced natural killer cell activation by interleukin‐4

F. Mami-Chouaib, S. Chouaib, J. Thèze, 1996, European journal of immunology.

Use of Colloidal Silica (Sepracell‐MN) for Enrichment of Dendritic Cells From Human Peripheral Blood: Comparison With Other Methods

S. Douglas, H. Kawashima, J. Chehimi, 1990, Journal of leukocyte biology.

The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals.

G. Trinchieri, L. Montaner, J. Kostman, 1999, Blood.

Interleukin-12 in the pathogenesis and therapy of HIV disease.

G. Trinchieri, I. Frank, S. Chouaib, 1995, Research in immunology.

Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin‐12) on cell‐mediated cytotoxicity against tumor‐derived and virus‐infected cells

G. Trinchieri, N. Valiante, Michiko Kobayashi, 1993, European journal of immunology.

Differential production of interleukin 10 during human immunodeficiency virus infection.

L. Nissim, I. Frank, S. Chouaib, 1996, AIDS research and human retroviruses.

Dendritic and natural killer cell subsets associated with stable or declining CD4+ cell counts in treated HIV-1-infected children.

L. Montaner, L. Azzoni, J. Chehimi, 2005, The Journal of infectious diseases.

Inhibition of the human allogeneic mixed lymphocyte response by cyclosporin A: relationship with the IL-12 pathway.

J. Bourhis, B. Bonnotte, F. Mami-Chouaib, 1996, Tissue antigens.

Producer cells of interleukin 12.

G. Trinchieri, M. Kubin, N. Valiante, 1993, Parasitology today.

Dendritic Cells in HIV-Infected Individuals Therapy and Increased Blood Myeloid Effective Highly Active Antiretroviral Dendritic Cell Number and Function Despite Persistent Decreases in Blood Plasmacytoid

G. Trinchieri, L. Montaner, E. Papasavvas, 2002 .

Cellular and molecular immunology of an important regulatory cytokine. New York 9-12, November 1995.

S. Chouaib, B. Escudier, J. Chehimi, 1996, European cytokine network.

Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells

Giorgio, F. Stanley, R. Chizzonite, 1992, The Journal of experimental medicine.

Synthetic imidazoquinolines potently and broadly activate the cellular immune response of patients with cutaneous T-cell lymphoma: synergy with interferon-gamma enhances production of interleukin-12.

L. Montaner, J. Gelfand, A. Rook, 2007, Clinical lymphoma & myeloma.

Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells

L. Montaner, V. Maino, C. Rinaldo, 2007, AIDS.

Cytokine and chemokine dysregulation in hyper-IgE syndrome.

K. Sullivan, J. Winkelstein, E. R. Stiehm, 2001, Clinical immunology.

Elimination of mycoplasma, bacteria, and fungi contaminants of hybridoma cultures by intraperitoneal passage in the mouse.

J. Chehimi, J. Périès, M. Guillemin, 1984, Hybridoma.

The Diagnosis, Prevention and Treatment of Human Cytomegalovirus Infections Using Human and Murine Monoclonal Antibodies

U. Hämmerling, R. O'reilly, D. Emanuel, 1988 .

Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation.

J. Blay, J. Bourhis, B. Bonnotte, 1996, European cytokine network.

CD4-independent infection of human peripheral blood dendritic cells with isolates of human immunodeficiency virus type 1.

R. Collman, J. Chehimi, S. Bandyopadhyay, 1993, The Journal of general virology.

Impaired interleukin 12 production in human immunodeficiency virus- infected patients

G. Trinchieri, I. Frank, Xiaojing Ma, 1994, The Journal of experimental medicine.

NK Cell Lysis of HIV-1-Infected Autologous CD4 Primary T Cells: Requirement for IFN-Mediated NK Activation by Plasmacytoid Dendritic Cells1

L. Montaner, V. Maino, C. Tomescu, 2007, The Journal of Immunology.

Inability of Plasmacytoid Dendritic Cells To Directly Lyse HIV-Infected Autologous CD4+ T Cells despite Induction of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand

L. Montaner, E. Papasavvas, M. Pistilli, 2009, Journal of Virology.

Effect of hematopoietic growth factors on human blood monocytes/macrophages in in vitro culture.

W. Ho, S. Douglas, D. Campbell, 1994, Clinical and diagnostic laboratory immunology.

Morphological and functional differences between HLA-DR+ peripheral blood dendritic cells and HLA-DR+ IFN-alpha producing cells.

G. Trinchieri, S. Douglas, J. Chehimi, 1993, Advances in experimental medicine and biology.

HIV-1 infection of human peripheral blood, cord blood and tonsillar dendritic cells

W. Ho, J. Chehimi, S. Starr, 1996 .

HIV‐1 transmission and cytokine‐induced expression of DC‐SIGN in human monocyte‐derived macrophages

L. Montaner, L. Azzoni, Qi Luo, 2003, Journal of leukocyte biology.

Inability of Plasmacytoid Dendritic Cells To Directly Lyse HIV-Infected Autologous CD4 (cid:1) T Cells despite Induction of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (cid:1)

L. Montaner, E. Papasavvas, M. Pistilli, 2010 .

IL-15 enhances immune functions during HIV infection.

I. Frank, S. Chouaib, D. Bacheller, 1997, Journal of immunology.

Unique Cytokine/Chemokine Signatures for HIV-1 and HCV Mono-infection versus Co-infection as Determined by the Luminex® Analyses.

J. Connolly, S. Rahman, L. Montaner, 2011, Journal of clinical & cellular immunology.

Linked Immuno Sorbent Assay; GM-CSF: Granulocyte-Macrophage Colony-Stimulating Factor; HAART: Highly Active Antiretroviral Therapy; HCV: Hepatitis C Virus; HIV-1: Human Immunodeficiency Virus; IDU: Intravenous Drug User; IFN: Interferon; IL: Interleukin; MCP-1: Monocyte Chemoattractant Protein; MIP-

J. Connolly, S. Rahman, L. Montaner, 2011 .

Priming with IL-4 and IL-13 during HIV-1 infection restores in vitro IL-12 production by mononuclear cells of HIV-infected patients.

G. Trinchieri, G Trinchieri, S. Robertson, 1997, Journal of immunology.

The diagnostic, prophylactic, and therapeutic uses of monoclonal antibodies to human cytomegalovirus.

R. O'reilly, D. Emanuel, J. Chehimi, 1987, Transplantation proceedings.

Increased metallothionein gene expression, zinc, and zinc‐dependent resistance to apoptosis in circulating monocytes during HIV viremia

Malik Yousef, Louise Showe, L. Montaner, 2010, Journal of leukocyte biology.

This information is current as Plasmacytoid Dendritic Cells IFN-Mediated NK Activation by CD4 Primary T Cells: Requirement for NK Cell Lysis of HIV-1-Infected Autologous

V. Maino, J. Montaner, C. Tomescu, 2013 .

Retention of functional DC-NK cross-talk following up to 18 weeks therapy interruptions in chronically suppressed HIV type 1+ subjects.

L. Montaner, E. Papasavvas, M. Pistilli, 2010, AIDS research and human retroviruses.

Selection of an intravenous immune globulin for the immunoprophylaxis of cytomegalovirus infections: an in vitro comparison of currently available and previously effective immune globulins.

D. Emanuel, J. Chehimi, J. Peppard, 1987, Bone marrow transplantation.

Producer cells of interleukin-12.

G. Trinchieri, M. Kubin, N. Valiante, 1993, Immunology today.

Isolation and characterization of newborn rabbit brain-derived microglia.

L. Mccawley, S. Douglas, J. Chehimi, 1991, Clinical immunology and immunopathology.

Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cells

A. Burny, S. Chouaib, P. Liljeström, 1997, Gene Therapy.

CD 4-independent infection of human peripheral blood dendritic cells with isolates of human immunodeficiency virus type 1

R. Collman, J. Chehimi, V. Shanmugam, 2007 .

Retention of viability, cytotoxicity, and response to IL‐2, IL‐15, or IFN‐α by human NK cells after CD107a degranulation

L. Montaner, V. Maino, J. Chehimi, 2009, Journal of leukocyte biology.

Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients

P. Janmey, L. Montaner, E. Papasavvas, 2009, AIDS.

In-vitro infection of peripheral blood dendritic cells with human immunodeficiency virus-1 causes impairment of accessory functions.

J. Chehimi, S. Bandyopadhyay, S. Starr, 1993, Advances in experimental medicine and biology.